Elsevier

Gynecologic Oncology

Volume 87, Issue 2, November 2002, Pages 185-189
Gynecologic Oncology

Regular Article
Management of Invasive Carcinoma of the Uterine Cervix Associated with Pregnancy: Outcome of Intentional Delay in Treatment

https://doi.org/10.1006/gyno.2002.6813Get rights and content

Abstract

Objective. To investigate patients with invasive cervical carcinoma associated with pregnancy, with special reference to the maternal and neonatal outcomes after planned treatment delay to improve fetal maturity.

Methods. The medical records of 28 patients with invasive cervical carcinoma diagnosed during pregnancy or within 1 month after pregnancy were retrospectively reviewed.

Results. Twenty-two patients (79%) had Stage I disease and 6 (21%) had Stage II or III disease. Tumor histology revealed squamous cell carcinoma in 27 cases and adenocarcinoma in 1. Twenty cases were diagnosed before 22 weeks gestation, 4 between 22 and 36 weeks, 1 after 36 weeks gestation, and 3 were diagnosed postpartum. In the immediate treatment group (n = 16), the diseases were Stage IA in 3 cases, IB in 7, and II or III in 6. In 11 patients, hysterectomy was performed after therapeutic abortion or with fetus in situ. In 2 patients, cesarean section was followed by hysterectomy or radiotherapy. Three patients diagnosed postpartum were treated with either hysterectomy or radiotherapy. Fifteen patients were free of disease during the follow-up of 27 to 114 months. In the delayed treatment group (n = 12), the diseases were Stage IA1 in 8 cases, IA2 in 1, IB1 in 2, and IB2 in 1 case. In 8 patients with Stage IA1 tumor, the treatment was deferred until term with a delay of 6 to 25 weeks, and hysterectomy or therapeutic conization was performed after delivery. In 4 patients with Stage IA2, IB1 or IB2 tumor, the treatment was postponed until after 30 weeks gestation with a delay of 6 to 15 weeks. No disease progression was documented. Cesarean delivery was followed by hysterectomy in these patients. All patients were free from disease during the follow-up of 70 to 156 months and their babies were well with no sequelae.

Conclusion. Delay in treatment to allow for fetal maturity is safe in patients with early Stage I cervical carcinoma associated with pregnancy.

Cited by (93)

  • Cancer in pregnancy

    2023, DiSaia and Creasman Clinical Gynecologic Oncology
  • Rapid progression of cervical squamous cell carcinoma with delayed treatment in pregnancy

    2022, Gynecologic Oncology Reports
    Citation Excerpt :

    Based on these factors, women with early stage macroscopic invasive cervical carcinoma diagnosed prior to fetal viability have historically been recommended to terminate the pregnancy for immediate definitive cancer treatment to both optimize their cancer prognosis and mitigate potential maternal morbidity and mortality (Hunter et al., 2008). Notably, disease progression associated with planned treatment delay in pregnancy is not common (Takushi et al., 2002 Nov). Additionally, there is significant consideration of the patient’s wishes regarding the continuation of pregnancy and delaying treatment in recognition of complex cultural, ethical, religious and personal dilemmas inherent to influencing this decision (Hunter et al., 2008; Gurney and Blank, 2009).

  • Cancer in Pregnancy

    2018, Obstetrics and Gynecology Clinics of North America
View all citing articles on Scopus
1

To whom correspondence should be addressed at Department of Obstetrics and Gynecology, Faculty of Medicine, University of the Ryukyus, 207 Uehara Nishihara-Machi, Nakagami-Gun, Okinawa, Japan. Telephone: 098-895-1175. Fax: 098-895-1426.

View full text